![](/en/uploads/20240202/c233135e7866dad4545dc58a167cc98d.png)
© Olga Danov
A research team from the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM and the Hannover Medical School (MHH) have made significant progress in developing a new antiviral therapy. The drug, which is inhaled, uses RNAi to target and deactivate parainfluenza viruses before they multiply.
MORE
MORE